Delivery Order SPE2DB24D2012-SPE2DB25FBWDG

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S, a pharmaceutical product, with a ceiling value of $1,944.55. The contract is a firm fixed-price delivery order, with a performance period ending on May 13, 2025. The contract is not set-aside and was competitively awarded....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S, a pharmaceutical product, with a firm fixed price ceiling value of $8,482.73. The period of performance extends to May 19, 2025. This delivery order is not set aside and was awarded on an open competition basis....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,704.76, is for the delivery of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S, a pharmaceutical product. The contract is a Firm Fixed Price contract with a completion date of November 6, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a $6,042.93 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S, a pharmaceutical product. The contract has an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 unit capsules of CREON DR 4568219391, with an ultimate completion date of May 13, 2025. The contract has a ceiling value of $4,540.76 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,803.58, is for the delivery of 36,000 unit capsules of the drug CREON DR over a period ending on May 21, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,302.31 and is for the delivery of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 22, 2025. This award is not associated with a set-aside program....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 units of CREON DR 36,000 UNIT CAPSULE in 100-count packages, with a ceiling value of $9,069.54 and a completion date of May 22, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the prime...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,305.75 firm-fixed-price contract is for the delivery of 36,000 units of the medication CREON DR 36,000 UNIT CAPSULE UU 100S. The contract has a completion date of June 5, 2025 and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA...
This is a $23,291.93 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 36,000 unit capsules of CREON DR medication, with a completion date of May 28, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBWDG
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S, a medical product, with a firm fixed price ceiling value of $27,196.10. The contract has an ultimate completion date of June 6, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 9/4/25, 9:56 AM